Myasthenia gravis presents as a chronic autoimmune illness. In this state, the body's immune defense mechanism mistakenly targets the nerve cells that control muscular actions. This disruption leads to muscle weakness, which aggravates with use and improves with inactivity. Symptoms can differ widely from person to person, but common manifestation

Famotidine represents a histamine H2-receptor antagonist, effectively inhibiting the production of gastric acid. This action reduces the symptoms of various gastrointestinal disorders, such as peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Famotidine's pharmacokinetic profile demonstrates a relatively long ha